Russia's RDIF signs deal to produce Sputnik V vaccine in China

 Russia’s RDIF sovereign wealth fund and China’s Shenzhen Yuanxing Gene-tech have agreed to produce over 60 million doses of Russia’s Sputnik V vaccine against COVID-19 in China, RDIF said on Monday.

RDIF, which is marketing Sputnik V globally, said that commercial production was due to start in May.

https://www.reuters.com/article/us-health-coronavirus-vaccine-russia-chi/russias-rdif-signs-deal-to-produce-sputnik-v-vaccine-in-china-idUSKBN2BL0Y7